130 related articles for article (PubMed ID: 16909912)
1. Decreased fidelity in replicating DNA methylation patterns in cancer cells leads to dense methylation of a CpG island.
Watanabe N; Okochi-Takada E; Yagi Y; Furuta JI; Ushijima T
Curr Top Microbiol Immunol; 2006; 310():199-210. PubMed ID: 16909912
[TBL] [Abstract][Full Text] [Related]
2. Decreased fidelity in replicating CpG methylation patterns in cancer cells.
Ushijima T; Watanabe N; Shimizu K; Miyamoto K; Sugimura T; Kaneda A
Cancer Res; 2005 Jan; 65(1):11-7. PubMed ID: 15665274
[TBL] [Abstract][Full Text] [Related]
3. Fidelity of the methylation pattern and its variation in the genome.
Ushijima T; Watanabe N; Okochi E; Kaneda A; Sugimura T; Miyamoto K
Genome Res; 2003 May; 13(5):868-74. PubMed ID: 12727906
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
6. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
[TBL] [Abstract][Full Text] [Related]
7. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
8. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae.
Enomoto S; Maekita T; Tsukamoto T; Nakajima T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
Cancer Sci; 2007 Dec; 98(12):1853-61. PubMed ID: 17900260
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
12. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation profiling using Infinium® assay.
Bibikova M; Le J; Barnes B; Saedinia-Melnyk S; Zhou L; Shen R; Gunderson KL
Epigenomics; 2009 Oct; 1(1):177-200. PubMed ID: 22122642
[TBL] [Abstract][Full Text] [Related]
14. Engineering CpG island DNA methylation in pluripotent cells through synthetic CpG-free ssDNA insertion.
Tompkins J; Lizhar E; Shokrani A; Wu X; Berley J; Kamali D; Hussey D; Cerneckis J; Kang TH; Wang J; Tsark W; Zeng D; Godatha S; Natarajan R; Riggs A
Cell Rep Methods; 2023 May; 3(5):100465. PubMed ID: 37323577
[TBL] [Abstract][Full Text] [Related]
15. Fundamental diversity of human CpG islands at multiple biological levels.
Zeng J; Nagrajan HK; Yi SV
Epigenetics; 2014 Apr; 9(4):483-91. PubMed ID: 24419148
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.
Karpinski P; Pesz K; Sasiadek MM
Epigenomics; 2017 Nov; 9(11):1341-1352. PubMed ID: 28960094
[TBL] [Abstract][Full Text] [Related]
17. Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells.
Takahashi Y; Wu J; Suzuki K; Martinez-Redondo P; Li M; Liao HK; Wu MZ; Hernández-Benítez R; Hishida T; Shokhirev MN; Esteban CR; Sancho-Martinez I; Belmonte JCI
Science; 2017 May; 356(6337):503-508. PubMed ID: 28473583
[TBL] [Abstract][Full Text] [Related]
18. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
19. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
20. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
